Citations

Showing 10 of 108083 citations.

Cover Image, Volume 177B, Number 1, January 2018
Petrucelli, Leonard , Strong, Michael J. , Strong, Michael J , Farhan, Sali M K , Gendron, Tania F. , Hegele, Robert Alexander

Mayo Clinic

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics | December 12, 2017 | Volume: 177 | Issue: 1 | Pages: No page available

10.1002/ajmg.b.32617 Get It

Celiac disease is uncommon in irritable bowel syndrome in the USA
Almazar, Ann E., Larson, Joseph J. , Atkinson, Elizabeth J. , Saito, Yuri A. , Talley, Nicholas J. , Murray, Joseph A.

Mayo Clinic

European Journal of Gastroenterology & Hepatology | December 12, 2017 | Volume: 30 | Issue: 2 | Pages: 149-154

10.1097/meg.0000000000001022 | PMID 29240001 Get It

Background and aimsRoutine serologic testing for celiac disease (CD) may be useful in irritable bowel syndrome (IBS) patients, but this is controversial. We aimed to compare the prevalence of unrecognized CD in a large cohort of patients with and without IBS.Participants and methodsThis is a family case–control IBS study conducted at a single US academic medical center. Stored serum and DNA were available. Tissue transglutaminase (TTg) immunoglobulin A was performed, followed by indirect immunofluorescence testing for endomysial antibodies with positive or weakly positive TTg results. Individuals were considered to have CD if both results were positive.χ2and Fisher’s exact tests were used to compare prevalence between the two groups.ResultsSerum samples were studied from 533 cases and 531 controls. In all, 80% of participants were female, with a median age of 50 years; 65% of cases and 0% controls met the Rome criteria for IBS. Previous serological testing for CD had occurred in 142 (27%) cases and 13 (2%) controls, but none had CD on subsequent testing. Six (1.1%) cases versus five (0.9%) controls had positive or weakly positive TTg test. Six cases (1.1%) versus three (0.6%) controls were confirmed to have CD by endomysial antibody (P=0.51).ConclusionNo difference in the prevalence of CD between patients with IBS and patients without IBS at a tertiary medical center was observed. Our findings do not support routine celiac serologic or genetic testing in patients with IBS in all US populations.
Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia
Ngankeu, Apollinaire, Ranganathan, Parvathi , Havelange, Violaine , Volinia, Stefano , Powell, Bayard L., Kolitz, Jonathan E. , Uy, Geoffrey L. , Stone, Richard M. , Bloomfield, Clara D. , Garzon, Ramiro , Nicolet, Deedra , Kornblau, Steven M. , Andreeff, Michael , Croce, Carlo Maria , Uy, Geoffrey

Mayo Clinic

Oncotarget | December 12, 2017 | Volume: 9 | Issue: 4 | Pages: 4354-4365

10.18632/oncotarget.23150 | PMID 29435107 Get It

Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation
Porrata, Luis F.

Mayo Clinic

Journal of Clinical Apheresis | December 12, 2017 | Volume: 33 | Issue: 3 | Pages: 324-330

10.1002/jca.21611 | PMID 29232011 Get It

In addition to stem cells, T‐cells, natural killer cells, dendritic cells, and monocytes are also collected and infused from the autograft in patients undergoing autologous peripheral blood hematopoietic stem cell transplantation. Recent reports have shown that these autograft immune effector cells can affect the clinical outcome postautologous peripheral blood hematopoietic stem cell transplantation. In this article, I will review the clinical impact on the survival of these autograft immune effector cells conferring the concept of autologous graft versus tumor effect.
Surgical Treatment of Chronic Elbow Dislocation Allowing for Early Range of Motion: Operative Technique and Clinical Results
Anderson, Duane R. , Anderson, Lucas A. , Hailu, Samuel , Chala, Abebe, O’Driscoll, Shawn W. , OʼDriscoll, Shawn W, Fitzsimmons, James S , Haller, Justin M.

Mayo Clinic

Journal of Orthopaedic Trauma | December 12, 2017 | Volume: 32 | Issue: 4 | Pages: 196-203

10.1097/bot.0000000000001097 | PMID 29240012 Get It

Objectives: To describe the surgical treatment and patient outcomes of chronic elbow dislocations. Design: Retrospective review. Setting: Two tertiary referral centers. Patients/Participants: All patients with surgically treated chronic elbow dislocation with no associated articular fracture from January 2009 to January 2015. Intervention: Review of patient demographics, injury chronicity, surgical technique, and patient outcomes. Main Outcome Measurement: Clinical outcomes included elbow range of motion and complications. Radiographic outcomes included the presence of heterotopic ossification. Patient-reported outcomes included the Mayo Elbow Performance Index (MEPI) and the Summary Outcome Determination (SOD). Results: Thirty-two patients with mean follow-up of 22 months (range, 13–41 months) were included. The mean dislocation duration was 6 months (range, 1–34 months). The mean preoperative range of motion was 8 degrees (range, 0–30 degrees). There were no infections or recurrent dislocations. One patient developed transient ulnar nerve palsy postoperatively. There were no cases of new or progressive heterotopic ossification. The mean postoperative extension was 31 degrees (range, 0–75 degrees), and the mean postoperative flexion was 132 degrees (range, 95–150 degrees); the mean final arc of motion was 101 degrees (range, 50–140 degrees). The mean postoperative MEPI was 93 (range, 70–100), and the mean SOD score was 9 (range, 6–10). Using the MEPI, 97% (31/32 patients) had good or excellent outcome. There was no difference in flexion/extension arc or MEPI scores between groups of elbows older and younger than 17 years or dislocations less or more than 3 months. Conclusion: This is the largest case series of surgically treated patients with chronic elbow dislocation. Using our surgical technique, 97% of patients had good or excellent outcome with a low complication rate. Open reduction of chronic elbow dislocation can be accomplished while permitting early motion with minimal recurrent dislocation risk. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Developing a Newborn Resuscitation Telemedicine Program: A Comparison of Two Technologies
Beck, Jenna, Jensen, Julie A., Putzier, Rochelle, Stubert, Lisa, Stuart, Kathleen D., Mohammed, Hussain, Kreofsky, Beth L. , Boles, Kelly W., Colby, Christopher E. , Fang, Jennifer L. , Beck, Jenna A, Putzier, Rochelle F, Stubert, Lisa A

Mayo Clinic

Telemedicine and e-Health | December 12, 2017 | Volume: 24 | Issue: 7 | Pages: 481-488

10.1089/tmj.2017.0121 | PMID 29232175 Get It

Symptoms Reported by Frail Elderly Adults Independently Predict 30‐Day Hospital Readmission or Emergency Department Care
Borkenhagen, Lynn S., Havyer, Rachel D. , Naessens, James M. , Takahashi, Paul Y. , Peterson, Stephanie M, Takahashi, Paul , McCoy, Rozalina G. , Peterson, Stephanie M. Peck

Mayo Clinic

Journal of the American Geriatrics Society | December 12, 2017 | Volume: 66 | Issue: 2 | Pages: 321-326

10.1111/jgs.15221 | PMID 29231962 Get It

Objectives To assess the degree to which self‐reported symptoms predict unplanned readmission or emergency department ( ED ) care within 30 days of high‐risk, elderly adults enrolled in a posthospitalization care transition program ( CTP ). Design Retrospective cohort study. Setting Posthospitalization CTP at Mayo Clinic, Rochester, Minnesota, from January 1, 2013, through March 3, 2015. Participants Frail, elderly adults (N = 230; mean age 83.5 ± 8.3, 46.5% male). Measurements Charlson Comorbidity Index ( CCI ) and self‐reported symptoms, measured using the Edmonton Symptom Assessment System ( ESAS ), were ascertained upon CTP enrollment. Results Mean CCI was 3.9 ± 2.3. Of 51 participants returning to the hospital within 30 days of discharge, 13 had ED visits, and 38 were readmitted. Age, sex, and CCI were not significantly different between returning and nonreturning participants, but returning participants were significantly more likely to report shortness of breath ( P = .004), anxiety ( P = .02), depression ( P = .02), and drowsiness ( P = .01). Overall ESAS score was also a significant predictor of hospital return ( P = .01). Conclusion Four self‐reported symptoms and overall ESAS score, but not CCI , ascertained after hospital discharge were strong predictors of hospital return within 30 days. Including symptoms in risk stratification of high‐risk elderly adults may help target interventions and reduce readmissions.
Faculty Opinions recommendation of Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study.
Ansell, Stephen M.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 12, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.732271714.793540231 Get It

Faculty Opinions recommendation of Investigation and management of IgM and Waldenström-associated peripheral neuropathies: recommendations from the IWWM-8 consensus panel.
Ansell, Stephen M.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 12, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727324752.793540230 Get It

Faculty Opinions recommendation of Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes.
Ansell, Stephen M.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | December 12, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.726586324.793540228 Get It